美国 · SEC FORM 4
Penumbra Inc
PEN · NYSE · CIK 0001321732 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
4 同一窗口内观察到的 Form 4 交易行
0 sales · 4 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,245,649
- 上期报告
- 1,805,942
- 日均成交量
- 472,607
- 回补天数
- 4.8
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
73 transaction lines in the latest 365-day window; 1,134 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Narayan Shruthi | 代扣税 (F) | Common Stock | 1,367 | USD 321.20 | USD 439,080 | SEC 申报 ↗ |
| 2026-09-15 | Narayan Shruthi | 代扣税 (F) | Common Stock | 1,230 | USD 318.43 | USD 391,669 | SEC 申报 ↗ |
| 2026-08-17 | Narayan Shruthi | 奖励／授予 (A) | Common Stock | 3,060 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Narayan Shruthi | 代扣税 (F) | Common Stock | 1,367 | USD 321.20 | USD 439,080 | SEC 申报 ↗ |
| 2026-09-15 | Narayan Shruthi | 代扣税 (F) | Common Stock | 1,230 | USD 318.43 | USD 391,669 | SEC 申报 ↗ |
| 2026-08-17 | Narayan Shruthi | 奖励／授予 (A) | Common Stock | 3,060 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-19 | Elsesser Adam | 赠与 (G) | Common Stock | 77,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-02 | Grewal Harpreet | 卖出 (S) | Common Stock | 100 | USD 328.22 | USD 32,822 | SEC 申报 ↗ |
| 2026-03-15 | Yuen Maggie | 代扣税 (F) | Common Stock | 186 | USD 336.18 | USD 62,529 | SEC 申报 ↗ |
| 2026-03-15 | Shiu Lambert | 代扣税 (F) | Common Stock | 150 | USD 336.18 | USD 50,427 | SEC 申报 ↗ |
| 2026-03-15 | Roberts Johanna | 代扣税 (F) | Common Stock | 186 | USD 336.18 | USD 62,529 | SEC 申报 ↗ |
| 2026-03-15 | Narayan Shruthi | 代扣税 (F) | Common Stock | 117 | USD 336.18 | USD 39,333 | SEC 申报 ↗ |
| 2026-03-02 | Yuen Maggie | 卖出 (S) | Common Stock | 2,432 | USD 342.30 | USD 832,474 | SEC 申报 ↗ |
| 2026-02-17 | Yuen Maggie | 奖励／授予 (A) | Common Stock | 2,630 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-17 | Shiu Lambert | 奖励／授予 (A) | Common Stock | 2,300 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-17 | Roberts Johanna | 奖励／授予 (A) | Common Stock | 2,630 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-17 | Narayan Shruthi | 奖励／授予 (A) | Common Stock | 2,630 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-15 | Yuen Maggie | 代扣税 (F) | Common Stock | 481 | USD 339.30 | USD 163,203 | SEC 申报 ↗ |
| 2026-02-15 | Shiu Lambert | 代扣税 (F) | Common Stock | 412 | USD 339.30 | USD 139,792 | SEC 申报 ↗ |
| 2026-02-15 | Roberts Johanna | 代扣税 (F) | Common Stock | 482 | USD 339.30 | USD 163,543 | SEC 申报 ↗ |
| 2026-02-15 | Narayan Shruthi | 代扣税 (F) | Common Stock | 705 | USD 339.30 | USD 239,206 | SEC 申报 ↗ |
| 2026-02-13 | Yuen Maggie | 奖励／授予 (A) | Common Stock | 2,630 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-13 | Wilder Thomas | 奖励／授予 (A) | Common Stock | 589 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-13 | Shiu Lambert | 奖励／授予 (A) | Common Stock | 2,300 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-13 | Sarna Surbhi | 奖励／授予 (A) | Common Stock | 589 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-13 | Roberts Johanna | 奖励／授予 (A) | Common Stock | 2,630 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-13 | O'Rourke Bridget | 奖励／授予 (A) | Common Stock | 589 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-13 | Narayan Shruthi | 奖励／授予 (A) | Common Stock | 2,630 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-13 | Leeds Janet | 奖励／授予 (A) | Common Stock | 589 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-13 | Grewal Harpreet | 奖励／授予 (A) | Common Stock | 589 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-13 | Bose Arani | 奖励／授予 (A) | Common Stock | 589 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-15 | Narayan Shruthi | 代扣税 (F) | Common Stock | 286 | USD 350.49 | USD 100,240 | SEC 申报 ↗ |
| 2026-01-06 | Grewal Harpreet | 卖出 (S) | Common Stock | 186 | USD 312.64 | USD 58,151 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | PEN |
| CIK | 0001321732 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 1,134 transaction lines from 2020-01-02 to 2026-10-15 0 P purchase lines · 917 S sale lines · 217 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.